Highlights
Medication Treatment for Substance Abuse Up in Facilities
FRIDAY, Jan. 18, 2019 -- From 2007 to 2016, there was an increase in the proportion of substance use treatment facilitie
What does the NHS Long-Term Plan mean for pharmacy?
While the profession features prominently as a way to boost primary care and improve the use of medicines in the health
What does the 'NHS Long-Term Plan' mean for pharmacy?
While pharmacy features prominently as a way to boost primary care and improve the use of medicines in the health servic
At Risk for Breast Cancer? Your Race Matters
FRIDAY, Jan. 18, 2019 -- Black women at risk of breast cancer may face a disadvantage because of racial disparities in h
Walgreens Boots Alliance partners with Microsoft to develop 'new healthcare delivery m
Walgreens Boots Alliance and Microsoft have signed a seven-year deal that will see the technology company become the IT
RPS members to advise government on the misuse of drugs
Two members of the Royal Pharmaceutical Society have been appointed to the Advisory Council on the Misuse of Drugs, an e
Virtual Doctor Visits Get High Marks in New Survey
FRIDAY, Jan. 18, 2019 -- The quality of your care won't suffer if you choose video visits with your doctor, a new st
FMD compliance to be part of pharmacy inspections
Existing pharmacy inspection processes will be used to monitor pharmacies’ compliance with the Falsified Medicine
AHA: Taking Medicine for a Cold? Be Mindful of Your Heart
FRIDAY, Jan. 18, 2019 (American Heart Association) -- Flu has so far infected more than 6 million Americans this season,
Big Pharma's Marketing to Docs Helped Trigger Opioid Crisis: Study
FRIDAY, Jan. 18, 2019 -- Aggressive direct marketing to doctors by pharmaceutical companies is tied to spurring the ongo
Frailty Could Increase Susceptibility for Dementia
FRIDAY, Jan. 18, 2019 -- Frailty and Alzheimer disease-related brain changes independently contribute to dementia status
Oral Hepatoselective Glucokinase Activator Promising in T2DM
FRIDAY, Jan. 18, 2019 -- Use of the oral hepatoselective glucokinase activator (GKA) TTP399 for type 2 diabetes does not